Related references
Note: Only part of the references are listed.Dual Induction of Mitochondrial Apoptosis and Senescence in Chronic Myelogenous Leukemia by Myrtucommulone A
Cindy Grandjenette et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2015)
Expression and functional activity of the bitter taste receptors TAS2R1 and TAS2R38 in human keratinocytes
U Wölfle et al.
PLANTA MEDICA (2014)
Protonophore properties of hyperforin are essential for its pharmacological activity
Thomas S. Sell et al.
SCIENTIFIC REPORTS (2014)
Oligomycin A enhances apoptotic effect of TRAIL through CHOP-mediated death receptor 5 expression
Long He et al.
MOLECULAR CARCINOGENESIS (2013)
Metabolic roles of AMPK and metformin in cancer cells
Yeon Kyung Choi et al.
MOLECULES AND CELLS (2013)
Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis
Anni I. Nieminen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mechanistic Insights into the Antileukemic Activity of Hyperforin
C. Billard et al.
CURRENT CANCER DRUG TARGETS (2012)
Myrtucommulone from Myrtus communis: Metabolism, Permeability, and Systemic Exposure in Rats
Kathleen Gerbeth et al.
PLANTA MEDICA (2012)
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Simon A. Hawley et al.
SCIENCE (2012)
Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway
Jin-Yun Liu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Total Synthesis of Myrtucommulone A
Hans Mueller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Toward a class-independent quantitative structure - Activity relationship model for uncouplers of oxidative phosphorylation
Simon Spycher et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Myrtucommulone from Myrtus communis induces apoptosis in cancer cells via the mitochondrial pathway involving caspase-9
Irina Tretiakova et al.
APOPTOSIS (2008)
Hyperforin:: More than an antidepressant bioactive compound?
Miguel A. Medina et al.
LIFE SCIENCES (2006)
Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia
C Quiney et al.
LEUKEMIA (2006)
Hyperforin, a new lead compound against the progression of cancer and leukemia?
C. Quiney et al.
LEUKEMIA (2006)
The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression
BG Heerdt et al.
CANCER RESEARCH (2005)
Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction
B Drew et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis
E Gottlieb et al.
CELL DEATH AND DIFFERENTIATION (2003)
The mitochondrial membrane potential (Δψm) in apoptosis;: an update
JD Ly et al.
APOPTOSIS (2003)
Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis
LA Shchepina et al.
ONCOGENE (2002)
Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811
PC Waldmeier et al.
MOLECULAR PHARMACOLOGY (2002)
Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis
CM Schempp et al.
ONCOGENE (2002)
ATP production in isolated mitochondria of procyclic Trypanosoma brucei
N Allemann et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells
CM Schempp et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
